Showing results (101-110 of 490) with videos related to
Sort By:
Pageof 49
Movement Disorders : Official Journal of the Movement Disorder Society|June 10, 2011
Long-term efficacy and mortality in Parkinson's disease patients treated with subthalamic stimulationMathias Toft, Bård Lilleeng, Jon Ramm-Pettersen, et al.Movement Disorders : Official Journal of the Movement Disorder Society|September 25, 2004
Parkinsonism, FXTAS, and FMR1 premutationsMathias Toft, Jan Aasly, Gina Bisceglio, et al.Parkinsonism & Related Disorders|December 22, 2018
Parkinson's disease in Nigeria: A review of published studies and recommendations for future researchOluwafemi G Oluwole, Helena Kuivaniemi, Jonathan A Carr, et al.Neurobiology of Aging|February 10, 2020
Screening of the glucocerebrosidase (GBA) gene in South Africans of African ancestry with Parkinson's diseaseAmokelani C Mahungu, David G Anderson, Anastasia C Rossouw, et al.Age (Dordrecht, Netherlands)|July 11, 2012
Mitochondrial J haplogroup is associated with lower blood pressure and anti-oxidant status: findings in octo/nonagenarians from the BELFAST StudyIrene Maeve Rea, Susan E McNerlan, G Pooler Archbold, et al.Immunity & Ageing : I & A|August 21, 2013
Killer Immunoglobulin-like Receptors (KIR) haplogroups A and B track with Natural Killer Cells and Cytokine Profile in Aged Subjects: Observations from Octo/Nonagenarians in the Belfast Elderly Longitudinal Free-living Aging STudy (BELFAST)Irene Maeve Rea, Lynn D Maxwell, Susan E McNerlan, et al.BMC Research Notes|April 1, 2014
Frequency of APOE, MTHFR and ACE polymorphisms in the Zambian populationMasharip Atadzhanov, Mwila H Mwaba, Patrice N Mukomena, et al.Plos One|October 13, 2017
Correction: Targeted high throughput sequencing in hereditary ataxia and spastic paraplegiaZafar Iqbal, Siri L Rydning, Iselin M Wedding, et al.Acta Neuropathologica|November 5, 2014
Hippocampal sclerosis in Lewy body disease is a TDP-43 proteinopathy similar to FTLD-TDP Type ANaoya Aoki, Melissa E Murray, Kotaro Ogaki, et al.Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|January 3, 2021
Cilostazol Versus Aspirin for Secondary Stroke Prevention: Systematic Review and Meta-AnalysisMichelle P Lin, James F Meschia, Neethu Gopal, et al.Pageof 49